Literature DB >> 31796871

Excellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemia.

Martin Sula1, Ulrike Bacher2,3, Elisabeth Oppliger Leibundgut2, Behrouz Mansouri Taleghani2, Urban Novak1, Thomas Pabst4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31796871     DOI： 10.1038/s41409-019-0762-3

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Autologous hematopoietic cell transplantation following high-dose cytarabine consolidation for core-binding factor-acute myeloid leukemia in first complete remission: a phase 2 prospective trial.

Authors:  Eun-Ji Choi; Je-Hwan Lee; Hawk Kim; Yunsuk Choi; Won-Sik Lee; Sang-Min Lee; Jun-Hong Park; Han-Seung Park; Jung-Hee Lee; Kyoo-Hyung Lee
Journal:  Int J Hematol       Date:  2021-03-02       Impact factor: 2.490

2.  Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML.

Authors:  Ekaterina Gurevich; Michael Hayoz; Yolanda Aebi; Carlo R Largiadèr; Behrouz Mansouri Taleghani; Ulrike Bacher; Thomas Pabst
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

3.  Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation.

Authors:  Evgenii Shumilov; Inna Shakhanova; Johanna Flach; Nicole Schmidt; Susanne Buerki; Myriam Legros; Marie-Noëlle Kronig; Yishai Ofran; Sabine Gerull; Michael Medinger; Behrouz Mansouri Taleghani; Jakob Passweg; Jörg Halter; Ulrike Bacher; Thomas Pabst
Journal:  Bone Marrow Transplant       Date:  2021-11-13       Impact factor: 5.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.